Parkside Financial Bank & Trust’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-84
Closed 1677
2019
Q3
$0 Buy
+84
New +$470 ﹤0.01% 1707
2019
Q1
Sell
-39
Closed -$1K 1702
2018
Q4
$1K Hold
39
﹤0.01% 1410
2018
Q3
$1K Hold
39
﹤0.01% 1480
2018
Q2
$1K Sell
39
-53
-58% -$1.24K ﹤0.01% 1479
2018
Q1
$2K Sell
92
-1,518
-94% -$35.4K ﹤0.01% 1076
2017
Q4
$32K Sell
1,610
-116
-7% -$2.28K 0.01% 453
2017
Q3
$36K Sell
1,726
-222
-11% -$3.75K 0.01% 422
2017
Q2
$29K Sell
1,948
-11
-0.6% -$183 0.01% 449
2017
Q1
$31K Buy
1,959
+10
+0.5% +$144 0.01% 422
2016
Q4
$25K Buy
1,949
+1,838
+1,656% +$34.2K 0.01% 496
2016
Q3
$3K Buy
111
+40
+56% +$1.34K ﹤0.01% 936
2016
Q2
$2K Hold
71
﹤0.01% 967
2016
Q1
$2K Hold
71
﹤0.01% 941
2015
Q4
$2K Buy
+71
New +$2.21K ﹤0.01% 944

Other funds holding DPLO

Parkside Financial Bank & Trust's DPLO Position: Q4 2019 in Review

Parkside Financial Bank & Trust sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q4 2019, closing a stake of 84 shares.

Parkside Financial Bank & Trust first reported a position in DPLO in Q4 2015 and held it in 14 quarters. The position peaked at $36K in Q3 2017. 138 funds tracked by Wall St. Rank hold DPLO as of Q4 2019.

  • Parkside Financial Bank & Trust reported no remaining DIPLOMAT PHARMACY, INC. position as of Q4 2019 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 84 DIPLOMAT PHARMACY, INC. shares in Q4 2019.
  • Parkside Financial Bank & Trust first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2015 and held it in 14 quarters.
  • Parkside Financial Bank & Trust's DIPLOMAT PHARMACY, INC. position peaked at $36K in Q3 2017.
  • 138 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2019.

Based on Parkside Financial Bank & Trust's 13F filing for Q4 2019, filed 30 Jan 2020.